NanoVibronix Implements Reverse Stock Split to Maintain Nasdaq Compliance NanoVibronix, a medical technology company, has executed a 1-for-11 reverse stock split, effective March 13, 2025. This move reduces outstanding shares from 8.7 million to roughly 792,000. The split aims to boost share price and ensure Nasdaq listing compliance. Trading on a split-adjusted basis begins March 14, 2025.12